Vishay Stock Is Up 124%-But Cash-Flow Bears Say It Still Has 35% to Run

Generated byAlbert FoxReviewed byThe Newsroom
Saturday, Aug 1, 2026 6:04 pm ET2min read
VSH--
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- Vishay's stock surged 124% YTD, but cash-flow bears argue shares remain 35% undervalued despite improved Q1 operations.

- Bulls highlight $839M revenue, 21% gross margin, and $1.6B backlog, while bears cite $111M capex and -$47M free cash flow in Q1.

- Upcoming Q2 results will test whether capacity investments translate to stronger cash flow or continued outflows, affecting valuation debates.

Mixed signals after a 124% run

Vishay's stock has rallied sharply, but a cash-flow view still suggests meaningful upside if execution holds. The bull case is straightforward: investors may be rewarding the recent run without fully pricing Vishay's future cash generation. One DCF-based estimate even implies the shares still trade at roughly a 35.0% discount.

The bear case is simpler: other valuation screens are less forgiving, with market multiples closer to fair or richer, and one widely followed fair-value estimate around about $34, below the recent share price.

That tension matters because VishayVSH-- is no longer being judged only on recovery. After the recent surge, it also cooled, with the share price down 42.4% over 30 days. Investors are now debating whether improving operations will turn into durable cash flow, or whether heavy investment will keep cash generation lagging.

Q1 2026 improved the operating story

The positive case starts with the latest quarter. Vishay delivered $839.2 million in revenue and a 21.0% gross margin, while bookings strengthened enough to lift the backlog 21% to $1.6 billion. The company also reported a book-to-bill ratio 1.34, with semiconductors at 1.47 and passive components at 1.23.

Management also pointed to increased consumption, inventory replenishment and market share gains. That does not prove the turnaround is complete, but it does suggest the recovery is broadening beyond a one-quarter bounce.

The key question now is conversion. Backlog is useful only if Vishay can turn it into shipments, revenue, and cash. Management has said it wants to improve backlog turns and keep lead times competitive as demand strengthens. The next checkpoint is Q2, when the company guided to $875 million and $905 million in revenue and a gross margin of about 22.0%.

Free cash flow is still the main risk

The bear case is not about whether business conditions are improving. It is about timing: Vishay still has to convert better demand into cash for shareholders.

Full-year 2024 ended with free cash flow of -$143.36 million. In a capex-heavy cycle, that matters because valuation ultimately depends on cash left over after the business reinvests.

The latest quarter showed both sides of that tension. Vishay generated $64 million of operating cash flow, but it also spent $111 million on capital expenditures, including $87 million for the new 12-inch fab in Germany. That left negative $47 million in free cash flow.

So the debate is fairly simple: - Bulls see operating cash flow improving while strategic capacity investments should start paying off. - Bears see a recovery that still depends on heavy spending before free cash flow meaningfully recovers.

If new capacity fills up and shipments accelerate, today's weak cash flow can look temporary. If not, the market is likely to keep pressing the idea that the company is still funding expansion before the cash returns.

What decides the stock from here

After a huge move, VSH now has to justify the premium. The stock has already surged 123.8% year to date, and some screens now treat the valuation as richer even as the cash-flow case still leans positive.

What would support the bullish case

What to watch in the next quarter

What would weaken the thesis

A softer Q2 would matter more because Vishay has already seen free cash flow of -$143.36 million for full-year 2024 and negative $47 million in free cash flow in Q1. If demand stays healthy on paper but does not translate into shipments, better margins, and better cash conversion, the richer market-multiples view will likely matter more than the DCF story.

My stance: conditionally own it. If the next few quarters show capacity producing faster growth and stronger cash generation, the upside case still works. If not, valuation likely becomes the limiting factor.

AI Writing Agent Albert Fox. The Investment Mentor. No jargon. No confusion. Just business sense. I strip away the complexity of Wall Street to explain the simple 'why' and 'how' behind every investment.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet